Organigram Global Inc.
OGI · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -0.00 | -0.01 | 0.04 |
| FCF Yield | 2.03% | -12.34% | -2.21% | 2.76% |
| EV / EBITDA | 81.66 | -67.00 | -67.01 | 20.87 |
| Quality | ||||
| ROIC | -0.18% | -1.64% | -2.75% | 0.08% |
| Gross Margin | 36.93% | 28.08% | 32.33% | 38.52% |
| Cash Conversion Ratio | -2.32 | -0.39 | 0.18 | -1.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.59% | 5.26% | 1.52% | 3.11% |
| Free Cash Flow Growth | 121.61% | -297.87% | -183.05% | 246.06% |
| Safety | ||||
| Net Debt / EBITDA | -9.96 | 1.33 | 10.06 | -14.06 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.36 | 0.41 | 0.28 | 0.33 |
| Cash Conversion Cycle | 144.49 | 163.54 | 211.79 | 190.83 |